Pulmonology
Formoterol PSK
Registration certificate:
INN:
Formoterol
Release form:
Inhalation powder hard capsule
Therapeutic Area:
Pulmonology
Pharmacotherapeutic Group:
Bronchodilator – selective β2-adrenergic agonist
Conditions for dispensing:
On prescription
Packaging:

Indications for Use:

  • Prevention and treatment of bronchial obstruction in patients with bronchial asthma as an adjunct to inhaled corticosteroid therapy.
  • Prevention of exercise-induced bronchospasm, cold air, or allergen inhalation-induced bronchospasm as an adjunct to inhaled corticosteroid therapy.
  • Prevention and treatment of bronchial obstruction in patients with chronic obstructive pulmonary disease (COPD) with both reversible and irreversible bronchial obstruction, chronic bronchitis, and pulmonary emphysema.

This medication is included in the List of Essential Medicines.

Using Formoterol PSK
 
Quality control
at all stages of production